https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-pi3k-mtor-inhibitor-sf1126
Definition of pan-PI3K/mTOR inhibitor SF1126 - NCI Drug Dictionary - NCI
Find technical definitions and synonyms by letter for drugs/agents used to treat patients with cancer or conditions related to cancer. Each entry includes...
definition ofmtor inhibitorpanncidrug
https://pubmed.ncbi.nlm.nih.gov/29487226/
Emerging Perspectives on mTOR Inhibitor-Associated Pneumonitis in Breast Cancer
This article summarizes the pathogenesis, clinical presentation, incidence, detection, and optimal management of everolimus-related noninfectious pneumonitis...
mtor inhibitoremergingperspectivesassociatedbreast
https://pure.psu.edu/en/publications/therapeutic-approach-guided-by-genetic-alteration-use-of-mtor-inh/
Therapeutic approach guided by genetic alteration: Use of MTOR inhibitor in renal medullary...
https://boris-portal.unibe.ch/entities/publication/91c87c34-03bc-4f15-ad87-83ad3911ca1a
Pulse mTOR inhibitor treatment effectively controls cyst growth but leads to severe parenchymal and...
The efficacy of mammalian target of rapamycin (mTOR) inhibitors is currently tested in patients affected by autosomal dominant polycystic kidney disease....
https://pubmed.ncbi.nlm.nih.gov/37545094/
Seizure reduction in TSC2-mutant mouse model by an mTOR catalytic inhibitor
Novel mTOR catalytic inhibitor TC1 exhibits a promising therapeutic option in the treatment of TSC.
mouse model
https://pubs.rsc.org/en/Content/ArticleLanding/2016/MD/C5MD00493D
eCF309: a potent, selective and cell-permeable mTOR inhibitor - MedChemComm (RSC Publishing)
Kinase inhibitors capable of blocking the phosphorylation of protein substrates with high selectivity are essential to probe and elucidate the etiological role...
https://adisinsight.springer.com/trials/700197374?error=cookies_not_supported&code=1be83d3c-3dd2-4111-a706-8d3628d0fa22
A Phase I Dose Escalation Study of the mTOR Inhibitor Everolimus (RAD001) and Erlotinib...
This trial will investigate the tolerability and efficacy of everolimus alone and in combination with erlotinib concurrently with radiotherapy in patients with
https://open.library.emory.edu/concern/publications/520de740-71e3-494e-b259-b0f071a1a380
Phase I and pharmacokinetic study of everolimus, an mTOR inhibitor, in combination with docetaxel...
Phase I and pharmacokinetic study of everolimus, an mTOR inhibitor, in combination with docetaxel for recurrent/refractory non-small cell lung cancer
https://edoc.ub.uni-muenchen.de/14506/
Gezielte molekulare Therapie des Mantelzell-Lymphoms In vitro Wirksamkeit von mTOR-Inhibitor RAD001...
https://pubmed.ncbi.nlm.nih.gov/32219609/?dopt=Abstract
The PI3K/mTOR dual inhibitor BEZ235 nanoparticles improve radiosensitization of hepatoma cells...
Polymer materials encapsulating drugs have broad prospects for drug delivery. We evaluated the effectiveness of polyethylene glycol-poly (lactic-co-glycolic...